Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant Setting

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Research output: Contribution to journalReviewResearchpeer-review

  3. Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Some subgroups of breast cancer patients receiving neoadjuvant chemotherapy (NACT) show high rates of pathologic complete response (pCR) in the breast, proposing the possibility of omitting surgery. Prediction of pCR is dependent on accurate imaging methods. This study investigated whether magnetic resonance imaging (MRI) is better than ultrasound (US) in predicting pCR in breast cancer patients receiving NACT. Methods: This institutional, retrospective study enrolled breast cancer patients receiving NACT who were examined by either MRI or combined US and mammography before surgery from 2016 to 2019. Imaging findings were compared with pathologic response evaluation of the tumor. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for prediction of pCR were calculated and compared between MRI and US. Results: Among 307 patients, 151 were examined by MRI and 156 by US. In the MRI group, 37 patients (24.5 %) had a pCR compared with 51 patients (32.7 %) in the US group. Radiologic complete response (rCR) was found in 35 patients (23.2 %) in the MRI group and 26 patients (16.7 %) in the US group. In the MRI and US groups, estimates were calculated respectively for sensitivity (87.7 % vs 91.4 %), specificity (56.8 % vs 33.3 %), PPV (86.2 % vs 73.8 %), NPV (60.0 % vs 65.4 %), and accuracy (80.1 % vs 72.4 %). Conclusions: In predicting pCR, MRI was more specific than US, but not sufficiently specific enough to be a valid predictor of pCR for omission of surgery. As an imaging method, MRI should be preferred when future studies investigating prediction of pCR in NACT patients are planned.

Original languageEnglish
JournalAnnals of Surgical Oncology
Issue number12
Pages (from-to)7421-7429
Number of pages9
Publication statusPublished - Nov 2021

    Research areas

  • Breast Neoplasms/diagnostic imaging, Chemotherapy, Adjuvant, Female, Humans, Magnetic Resonance Imaging, Neoadjuvant Therapy, Retrospective Studies, Treatment Outcome, Ultrasonography

ID: 66208768